CME VIDEO | Top of page |
How to Obtain CME Credit: | Top of page |
Click here to take the CME Evaluation and Post-Meeting Survey
About the Presenter: | Top of page |
Learning Objectives: | Top of page |
1. Be aware of new developments in the HIV prevention space including the use of long-acting regimens for PrEP.
2. Be familiar with the new WHO HBV guidelines and appreciate the current advances and challenges in TB and hepatitis coinfection
3. Be aware of new resistance and diagnostic trends in STIs also after introduction of doxyPEP.
4. Appreciate a potential new HIV cure case from Berlin.
CME Information: | Top of page |
This CME activity has approved for AMA PRA Category 1 Credit™ for August 20, 2024, as a live activity. This activity will also be available as an enduring activity from August 27, 2024, through August 19, 2027.
The target audience is all physicians, NPs and PAs involved in or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
Accreditation Statement: | Top of page |
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement: | Top of page |
Disclosure Statement: | Top of page |
- Dr. James F. Braun (Course Director/Planner) has no relevant financial relationships to disclose.
- Dr. William M. Valenti (Moderator) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Research grants from Gilead and ViiV. All relevant financial relationships have been mitigated.
- Dr. Jürgen Rockstroh, MD (Presenter) has had the following personal financial relationships in the past 24 months with manufacturers of the products or services that may be presented in this CME activity: Consultant to Boehringer, MSD and ViiV; Advisor to Gilead and AbbVie; Speaker at Gilead, Janssen, MSD and ViiV. Dr. Rockstroh submitted his slides in advance for adequate peer review and will support his presentation and clinical recommendations with the best available evidence from the medical literature. All relevant financial relationships have been mitigated.
Financial Support: | Top of page |
This PRN CME activity is funded in part by unrestricted educational grants from Gilead Sciences and ViiV Healthcare and by a generous charitable contribution from Northwell Health Center for AIDS Research & Treatment.